Virpax Pharmaceuticals, Inc.
VRPXDelisted Jul 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708331
Virpax Pharmaceuticals, Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 10, 2024; 7 institutions reported holding it in 13F filings for Q1 2025, worth $34.9K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Virpax Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 7 | 13 | +6 |
| Shares | 245.6K | 2.38M | +2.14M (+870.6%) |
| Value | $1.12M | $11.4M | +$10.3M (+924.5%) |
New holders (9)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kepos Capital LP | 750,000 | $3.60M | 0.24% |
| Vanguard Group Inc | 279,020 | $1.34M | 0.00% |
| Altium Capital Management LP | 271,846 | $1.30M | 0.35% |
| Two Sigma Investments, LP | 25,715 | $123.0K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 19,420 | $93.0K | 0.00% |
| National Asset Management, Inc. | 18,600 | $90.0K | 0.00% |
| Geode Capital Management, LLC | 10,045 | $48.0K | 0.00% |
| Royal Bank of Canada | 100 | $0 | 0.00% |
| Advisor Group Holdings, Inc. | 88 | $0 | 0.00% |
Sold out (3)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Zeke Capital Advisors, LLC | 45,000 | $205.0K |
| HN Saltoro Capital, LP | 17,615 | $80.0K |
| UBS Group AG | 3,942 | $18.0K |